摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-氟硫代-4-色原酮 | 21243-18-5

中文名称
6-氟硫代-4-色原酮
中文别名
6-氟-4-硫色满酮;6-氟-2,3-二氢-4H-硫代色烯-4-酮
英文名称
6-fluorothiochroman-4-one
英文别名
6-Fluorothio-4-Chromanone;6-fluoro-2,3-dihydrothiochromen-4-one
6-氟硫代-4-色原酮化学式
CAS
21243-18-5
化学式
C9H7FOS
mdl
MFCD00078488
分子量
182.218
InChiKey
NBBGHADNMPMHST-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    89-92
  • 沸点:
    304.3±42.0 °C(Predicted)
  • 密度:
    1.335±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    42.4
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2932999099
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    存储条件:室温、干燥且密封保存。

SDS

SDS:a7eb123d6725969c4efd5ffb91db56b8
查看
Name: 6-Fluoro-2 3-dihydro-4h-thiochromen-4-one 95+% Material Safety Data Sheet
Synonym: 6-Fluorothiochroman-4-on
CAS: 21243-18-5
Section 1 - Chemical Product MSDS Name:6-Fluoro-2 3-dihydro-4h-thiochromen-4-one 95+% Material Safety Data Sheet
Synonym:6-Fluorothiochroman-4-on

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
21243-18-5 6-Fluoro-2,3-dihydro-4H-thiochromen-4- 95+% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 21243-18-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 89 - 92 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H7FOS
Molecular Weight: 182

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of sulfur, carbon dioxide, hydrogen fluoride gas, acrid smoke and fumes.
Hazardous Polymerization: Not available.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 21243-18-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
6-Fluoro-2,3-dihydro-4H-thiochromen-4-one - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 21243-18-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 21243-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 21243-18-5 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    —— (E)-3-(chloromethylene)-6-fluorothiochroman-4-one 1251531-01-7 C10H6ClFOS 228.674
    —— (Z)-3-(chloromethylene)-6-fluorothiochroman-4-one 1251530-87-6 C10H6ClFOS 228.674
    —— 6-fluorothiochroman-4-one 1,1-dioxide —— C9H7FO3S 214.217
    —— 6-Fluorothiochroman-4-amine 900641-17-0 C9H10FNS 183.25
    —— 6-fluorothiochroman-4-one thiosemicarbazone 259269-74-4 C10H10FN3S2 255.34

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Cu(I)催化噻吩酮的对映选择性炔基化。
    摘要:
    在温和的反应条件下,通过Cu(I)/亚磷酰胺催化硫代色酮的不对称炔基化反应,开发了一种高效的手性硫代铬烷酮不对称合成方法。该催化剂体系可耐受各种硫代色酮前体和末端炔烃。既定的不对称转化为不同的对映体富集的硫代发色酮提供了更高的分子复杂性,并使得可以通过进一步官能化获得手性硫代黄酮类化合物,这是类黄酮的一个子集。
    DOI:
    10.1021/acs.orglett.0c00005
  • 作为产物:
    描述:
    对氟苯硫酚硫酸 、 sodium carbonate 、 sodium hydroxide 作用下, 以 乙醇 为溶剂, 生成 6-氟硫代-4-色原酮
    参考文献:
    名称:
    Cu(I)催化噻吩酮的对映选择性炔基化。
    摘要:
    在温和的反应条件下,通过Cu(I)/亚磷酰胺催化硫代色酮的不对称炔基化反应,开发了一种高效的手性硫代铬烷酮不对称合成方法。该催化剂体系可耐受各种硫代色酮前体和末端炔烃。既定的不对称转化为不同的对映体富集的硫代发色酮提供了更高的分子复杂性,并使得可以通过进一步官能化获得手性硫代黄酮类化合物,这是类黄酮的一个子集。
    DOI:
    10.1021/acs.orglett.0c00005
点击查看最新优质反应信息

文献信息

  • Synthesis and antitumor activities of a new series of 4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine derivatives
    作者:DeXiang Guo、YaJing Liu、Ting Li、Nan Wang、Xin Zhai、Chun Hu、Ping Gong
    DOI:10.1007/s11426-011-4477-6
    日期:2012.3
    A new series of 4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine derivatives have been designed and synthesized. The antitumor activities of the target compounds have been evaluated in vitro against two human cancer cell lines including A549 (human alveolar adenocarcinoma cell) and H460 (human lung cancer) by MTT assay. Most of the target compounds exhibited significant antitumor activities against A549 and H460 cancer cell lines. The most potent compound 4-(benzo[d][1,3]dioxol-5-yl)-8,9-difluoro-2-(4-methylpiperazin-1-yl)-4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine (CH05) (IC50 = 0.44 μM, 3.07 μM) was 2.0 and 8.4 times more active than gefitinib (IC50 = 0.89 μM, 16.81 μM) against A549 and H460 cell lines, respectively.
    设计并合成了一系列4,5-二氢-1H-硫杂色满并[4,3-d]嘧啶衍生物。通过MTT法,在体外对两种人癌细胞系(包括A549(人肺泡腺癌细胞)和H460(人肺癌细胞))进行了目标化合物的抗肿瘤活性评估。大多数目标化合物对A549和H460癌细胞系表现出显著的抗肿瘤活性。其中最强效的化合物4-(苯并[d][1,3]二氧戊环-5-基)-8,9-二氟-2-(4-甲基哌嗪-1-基)-4,5-二氢-1H-硫杂色满并[4,3-d]嘧啶(CH05)(IC50 = 0.44 μM,3.07 μM)对A549和H460细胞系的活性分别是吉非替尼(IC50 = 0.89 μM,16.81 μM)的2.0倍和8.4倍。
  • Design and Synthesis of α,β-Epoxyketones as New Anticancer Agents
    作者:Zhengyue Ma、Xinghua Zhang、Shikui Wang、Yang He、Gengliang Yang、Beilei Li、Junjie Yang、Yuejuan Lu、Jiewei Sun
    DOI:10.1002/cjoc.201190153
    日期:2011.4
    As epoxy functional group has high anticancer activity, α,β‐epoxyketones were designed and synthesized as new anticancer agents, and their structures were confirmed by UV, 1H NMR, IR, MS technigeces and elemental analysis. Their in vitro anticancer activities were evaluated by MTT method and the results showed that the compound 4c exhibited good activity with IC50 of 17.8, 22.0 and 24.1 µg/mL against
    由于环氧官能团具有较高的抗癌活性,因此设计并合成了α,β-环氧酮作为新型抗癌剂,并通过UV,1 H NMR,IR,MS技术和元素分析确定了它们的结构。用MTT法评估了它们的体外抗癌活性,结果表明化合物4c对A-549,Hela和HepG2细胞的IC 50表现出良好的活性,IC 50分别为17.8、22.0和24.1 µg / mL。通过胃内给药的小鼠的LD50剂量为1864.4mg / kg。因此,α,β-环氧酮可能会提供新的抗癌药。
  • Synthesis and Antifungal Activity of Some Novel (E)-2, 3-Dihydro-3- [(phenylamino) methylene]-4H-1-benzothiopyran-4-ones
    作者:Liu Xiao-Ming、Yang Geng-Liang、Song Ya-Li、Liu Jie-Jie、Wang Yang、Zhang Dong- Nuan
    DOI:10.2174/1570178611310030016
    日期:2013.4.1
    A series of novel (E)-2,3-dihydro-3-[(phenylamino)methylene]-4H-1-benzothiopyran-4-ones has been synthesized by using 2,3-dihydro-4H-1-benzothiopyran-4-ones as the starting material. The structures of the new compounds are characterized by UV-vis, IR, HRMS, 1H NMR, and 13C NMR. 2D NMR spectroscopic studies revealed that at room temperature, these compounds rather exist in the keto-enamine than in the Schiff base form. The synthesized compounds were evaluated against two species of fungi in vitro by agar double dilution method. The results of antifungal screening revealed that the MIC value of (E)-8-chloro-2,3-dihydro-3-[(4-nitrophenylamino)methylene]-4H-1-benzothiopyran-4-one (4j) against Candida albicans is 32 μg·ml-1 while the control Fluconazole is 64 μg·ml-1.
    一系列新型(E)-2,3-二氢-3-[(苯氨基)亚甲基]-4H-1-苯并噻吩-4-酮通过2,3-二氢-4H-1-苯并噻吩-4-酮作为起始原料合成。新化合物的结构通过紫外-可见光谱、红外光谱、高分辨质谱、核磁共振氢谱和碳谱进行表征。二维核磁共振波谱学研究表明,在室温下,这些化合物更倾向于以酮胺形式存在而非席夫碱形式。合成的化合物通过琼脂双重稀释法在体外对抗两种真菌进行评估。抗真菌筛选结果显示,(E)-8-氯-2,3-二氢-3-[(4-硝基苯氨基)亚甲基]-4H-1-苯并噻吩-4-酮(4j)对白色念珠菌的最小抑制浓度值为32微克/毫升,而对照药物氟康唑为64微克/毫升。
  • Rh-Catalyzed Conjugate Addition of Arylzinc Chlorides to Thiochromones: A Highly Enantioselective Pathway for Accessing Chiral Thioflavanones
    作者:Ling Meng、Ming Yu Jin、Jun Wang
    DOI:10.1021/acs.orglett.6b02453
    日期:2016.10.7
    A highly efficient asymmetric synthesis of chiral thioflavanones is developed via conjugate addition of arylzinc reagents to thiochromones using Rh(COD)Cl2/(R)-3,4,5-MeO-MeOBIPHEP catalyst. This method overcomes catalyst poisoning and substrate inertness and affords a series of chiral thioflavanones (2-arylthiochroman-4-ones) in good yields (up to 91% yield) with excellent ee values (up to 97% ee)
    通过使用Rh(COD)Cl 2 /(R)-3,4,5-MeO-MeOBIPHEP催化剂将芳基锌试剂共轭添加到硫代色酮中,开发了一种高效的手性硫代黄酮酮的不对称合成方法。此方法克服了催化剂中毒和底物惰性的问题,并以良好的收率(最高91%的收率)和优异的ee值(最高ee的97%)提供了一系列手性硫代黄烷酮(2-芳基硫代色烷-4-酮)。既定的不对称合成为进一步的药物研究铺平了道路。
  • Cu-Catalyzed Conjugate Addition of Grignard Reagents to Thiochromones: An Enantioselective Pathway for Accessing 2-Alkylthiochromanones
    作者:Qingxiong Yang、Jun Wang、Shihui Luo、Ling Meng
    DOI:10.1055/s-0037-1610225
    日期:2018.9
    The enantioselective incorporation of alkyl groups in thiochromones was realized for the first time by a Cu/(R,S)-PPF-P t Bu2-catalyzed conjugate addition of Grignard reagents to thiochromones. With this method, a series of 2-methylthiochromanones were obtained in good yields (up to 96% yield) with moderate-to-good ee values (up to 87% ee). The established method expedites the synthesis of a large
    通过Cu/(R,S)-PPF-P t Bu2 催化的格氏试剂与硫色酮的共轭加成,首次实现了烷基在硫色酮中的对映选择性掺入。使用这种方法,以良好的收率(最高 96% 的收率)获得了一系列 2-甲基硫代色满酮,其 ee 值中等至良好(最高 87% ee)。已建立的方法加速了大型手性硫代色满酮库的合成,以用于进一步的合成应用和生物学研究。
查看更多

同类化合物

美替克仑 硫代苯并二氢吡喃-3-酮 硫代苯并二氢吡喃-3-胺盐酸盐 硫代苯并二氢吡喃-3-胺 硫代色满-4-酮 硫代色满 硫代-3,4-二氢苯并吡喃-4-醇 盐酸特他洛尔 他扎罗汀酸亚砜 N-叔-丁基-3-(3,4-二氢-2H-硫代色烯-8-氧基)-2-甲氧基丙烷-1-胺乙二酸酯 N-(3,4-二氢-4-氧代-2H-1-苯并噻喃-6-基)乙酰胺 8-甲氧基硫代色满-3-胺盐酸盐 8-甲氧基硫代色满-3-胺 8-氯-3,4-二氢-5-甲氧基-4-氧代-2H-1-苯并噻喃-2-乙酸 8-氟-2,3-二氢-4H-硫代色烯-4-酮 8-[3-[叔丁基氨基]-2-羟基丙氧基]-3,4-二氢-2H-1-苯并噻喃-4-醇 7-甲氧基硫代苯并二氢吡喃-4-酮 7-甲氧基硫代色满-3-胺 7-溴硫代苯并二氢吡喃-4-酮 6-硝基硫代苯并二氢吡喃-4-酮 6-甲氧基硫代苯并二氢吡喃-3-胺 6-甲基硫代苯并二氢吡喃-4-酮 6-甲基硫代色满 6-甲基-3,4-二氢-2H-苯并噻喃1,1-二氧化物 6-甲基-1,1-二氧代-3,4-二氢-2H-苯并噻喃-7-磺酰氯 6-溴硫代苯并二氢吡喃-4-酮 6-溴硫代苯并二氢吡喃-3-胺 6-溴-4,4-二甲基硫代苯并二氢吡喃 6-溴-3,4-二氢-2H-S,S-二-氧代-硫代色烯-4-胺盐酸盐 6-溴-3,4-二氢-2H-1-苯并噻喃-4-胺盐酸盐 6-溴-2,3-二氢硫代色烯-1,1-二氧化物-4-酮 6-氯硫代苯并二氢吡喃-4-酮 6-氯-2-甲基-3,4-二氢-2H-1-苯并噻因-4-酮 6-氯-2-甲基(硫苯并二氢吡喃-4-酮)-1,1-二氧化物 6-氯-1-苯并硫代吡喃-4-酮 1,1-二氧化物 6-氨基硫代苯并二氢吡喃-4-酮 6-氟硫代苯并二氢吡喃-3-胺 6-氟硫代-4-色原酮 6-乙酰基-4,4-二甲基二氢苯并噻喃 6-乙炔基-4,4-二甲基二氢苯并噻喃 6-[2-(3,4-二氢-4,4-二甲基-2H-1-苯并噻喃-6-基)乙炔基]-3-吡啶甲酸 6,7-二氟-2,3-二氢-4H-1-苯并噻喃-4-酮 5-甲氧基硫代苯并二氢吡喃-3-胺 5-(硫代色满-8-基氧基甲基)-1,3-恶唑烷-2-酮 5-(3,4-二氢-2H-硫代色烯-4-基)嘧啶-4(3H)-酮 4-氨基-6-溴-3,4-二氢-2H-s,s-二氧代-硫代色烯盐酸盐 4-氧代硫代苯并二氢吡喃-2-羧酸 4,4-二甲基硫代苯并二氢吡喃-6-甲醛 4,4-二甲基硫代色满 3-吡啶羧酸,6-[2-(3,4-二氢-2,2,4,4-四甲基-2H-1-苯并噻喃-7-基)乙炔基]-